<VariationArchive VariationID="126464" VariationName="NM_021625.5(TRPV4):c.1412_1414del (p.Phe471del)" VariationType="Deletion" Accession="VCV000126464" Version="29" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-07-29" DateCreated="2015-12-21" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="131991" VariationID="126464">
      <GeneList>
        <Gene Symbol="TRPV4" FullName="transient receptor potential cation channel subfamily V member 4" GeneID="59341" HGNC_ID="HGNC:18083" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="109783087" stop="109833398" display_start="109783087" display_stop="109833398" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="110220891" stop="110271211" display_start="110220891" display_stop="110271211" Strand="-" />
          </Location>
          <OMIM>605427</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_021625.5(TRPV4):c.1412_1414del (p.Phe471del)</Name>
      <CanonicalSPDI>NC_000012.12:109794405:AGAAG:AG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q24.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="109794406" stop="109794408" display_start="109794406" display_stop="109794408" variantLength="3" positionVCF="109794405" referenceAlleleVCF="TAGA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="110232211" stop="110232213" display_start="110232211" display_stop="110232213" variantLength="3" positionVCF="110232210" referenceAlleleVCF="TAGA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>F471del</ProteinChange>
      <ProteinChange>F411del</ProteinChange>
      <ProteinChange>F437del</ProteinChange>
      <ProteinChange>F364del</ProteinChange>
      <ProteinChange>F424del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.110232213_110232215del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.110232213_110232215del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.109794408_109794410del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.109794408_109794410del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_017090.1" sequenceAccession="NG_017090" sequenceVersion="1" change="g.44000_44002del">
            <Expression>NG_017090.1:g.44000_44002del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001177428.1" sequenceAccession="NM_001177428" sequenceVersion="1" change="c.1271_1273del">
            <Expression>NM_001177428.1:c.1271_1273del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001170899.1" sequenceAccession="NP_001170899" sequenceVersion="1" change="p.Phe424del">
            <Expression>NP_001170899.1:p.Phe424del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001177431.1" sequenceAccession="NM_001177431" sequenceVersion="1" change="c.1310_1312del">
            <Expression>NM_001177431.1:c.1310_1312del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001170902.1" sequenceAccession="NP_001170902" sequenceVersion="1" change="p.Phe437del">
            <Expression>NP_001170902.1:p.Phe437del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001177433.1" sequenceAccession="NM_001177433" sequenceVersion="1" change="c.1091_1093del">
            <Expression>NM_001177433.1:c.1091_1093del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001170904.1" sequenceAccession="NP_001170904" sequenceVersion="1" change="p.Phe364del">
            <Expression>NP_001170904.1:p.Phe364del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021625.5" sequenceAccession="NM_021625" sequenceVersion="5" change="c.1412_1414del" MANESelect="true">
            <Expression>NM_021625.5:c.1412_1414del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_067638.3" sequenceAccession="NP_067638" sequenceVersion="3" change="p.Phe471del">
            <Expression>NP_067638.3:p.Phe471del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_147204.2" sequenceAccession="NM_147204" sequenceVersion="2" change="c.1232_1234del">
            <Expression>NM_147204.2:c.1232_1234del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_671737.1" sequenceAccession="NP_671737" sequenceVersion="1" change="p.Phe411del">
            <Expression>NP_671737.1:p.Phe411del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_372" sequenceAccession="LRG_372">
            <Expression>LRG_372:g.44000_44002del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_372t1" sequenceAccession="LRG_372t1">
            <Expression>LRG_372t1:c.1412_1414del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_372p1" sequenceAccession="LRG_372p1" change="p.Phe471del">
            <Expression>LRG_372p1:p.Phe471del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021625.4" sequenceAccession="NM_021625" sequenceVersion="4" change="c.1412_1414delTCT">
            <Expression>NM_021625.4:c.1412_1414delTCT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA347802" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="605427.0016" DB="OMIM" />
        <XRef Type="rs" ID="515726154" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_021625.5(TRPV4):c.1412_1414del (p.Phe471del) AND Skeletal dysplasia" Accession="RCV000202564" Version="10">
        <ClassifiedConditionList TraitSetID="8256">
          <ClassifiedCondition DB="MedGen" ID="C0410528">Skeletal dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_021625.5(TRPV4):c.1412_1414del (p.Phe471del) AND not provided" Accession="RCV000756825" Version="29">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-01" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_021625.5(TRPV4):c.1412_1414del (p.Phe471del) AND Skeletal dysplasia and progressive central nervous system degeneration, lethal" Accession="RCV001376047" Version="9">
        <ClassifiedConditionList TraitSetID="66154">
          <ClassifiedCondition DB="MedGen" ID="C1865117">Skeletal dysplasia and progressive central nervous system degeneration, lethal</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-03-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_021625.5(TRPV4):c.1412_1414del (p.Phe471del) AND Metatropic dysplasia" Accession="RCV002279715" Version="9">
        <ClassifiedConditionList TraitSetID="1374">
          <ClassifiedCondition DB="MedGen" ID="C0265281">Metatropic dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2010-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_021625.5(TRPV4):c.1412_1414del (p.Phe471del) AND Charcot-Marie-Tooth disease axonal type 2C" Accession="RCV003505097" Version="1">
        <ClassifiedConditionList TraitSetID="1377">
          <ClassifiedCondition DB="MedGen" ID="C1853710">Charcot-Marie-Tooth disease axonal type 2C</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-03" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-01" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2015-12-21" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20425821</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20577006</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21573172</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22791502</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">24830047</ID>
          <ID Source="BookShelf">NBK201366</ID>
        </Citation>
        <DescriptionHistory Dated="2021-05-04">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-02-17">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="8256" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9568" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Primary bone dysplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Skeletal dysplasia</ElementValue>
                <XRef ID="HP:0002652" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0018230" DB="MONDO" />
                <XRef ID="105986008" DB="SNOMED CT" />
              </Name>
              <Citation Type="general" Abbrev="ACMG, 2021">
                <ID Source="PubMed">33514815</ID>
              </Citation>
              <XRef ID="364526" DB="Orphanet" />
              <XRef ID="C0410528" DB="MedGen" />
              <XRef ID="MONDO:0018230" DB="MONDO" />
              <XRef Type="primary" ID="HP:0002652" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005685" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1374" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2773" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Metatropic dwarfism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Metatropic dysplasia</ElementValue>
                <XRef ID="MONDO:0007986" DB="MONDO" />
                <XRef ID="22764001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Metatropic dysplasia, nonlethal dominant</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MTD</ElementValue>
                <XRef Type="MIM" ID="156530" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3571" />
                <XRef ID="3571" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The autosomal dominant TRPV4 disorders (previously considered to be clinically distinct phenotypes before their molecular basis was discovered) are now grouped into neuromuscular disorders and skeletal dysplasias; however, the overlap within each group is considerable. Affected individuals typically have either neuromuscular or skeletal manifestations alone, and in only rare instances an overlap syndrome has been reported. The three autosomal dominant neuromuscular disorders (mildest to most severe) are: Charcot-Marie-Tooth disease type 2C. Scapuloperoneal spinal muscular atrophy. Congenital distal spinal muscular atrophy. The autosomal dominant neuromuscular disorders are characterized by a congenital-onset, static, or later-onset progressive peripheral neuropathy with variable combinations of laryngeal dysfunction (i.e., vocal fold paresis), respiratory dysfunction, and joint contractures. The six autosomal dominant skeletal dysplasias (mildest to most severe) are: Familial digital arthropathy-brachydactyly. Autosomal dominant brachyolmia. Spondylometaphyseal dysplasia, Kozlowski type. Spondyloepiphyseal dysplasia, Maroteaux type. Parastremmatic dysplasia. Metatropic dysplasia. The skeletal dysplasia is characterized by brachydactyly (in all 6); the five that are more severe have short stature that varies from mild to severe with progressive spinal deformity and involvement of the long bones and pelvis. In the mildest of the autosomal dominant TRPV4 disorders life span is normal; in the most severe it is shortened. Bilateral progressive sensorineural hearing loss (SNHL) can occur with both autosomal dominant neuromuscular disorders and skeletal dysplasias.</Attribute>
                <XRef ID="NBK201366" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24830047</ID>
                <ID Source="BookShelf">NBK201366</ID>
              </Citation>
              <XRef ID="2635" DB="Orphanet" />
              <XRef ID="C0265281" DB="MedGen" />
              <XRef ID="MONDO:0007986" DB="MONDO" />
              <XRef Type="MIM" ID="156530" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="66154" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3733" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Skeletal dysplasia and progressive central nervous system degeneration, lethal</ElementValue>
                <XRef ID="MONDO:0011263" DB="MONDO" />
              </Name>
              <XRef ID="C1865117" DB="MedGen" />
              <XRef ID="MONDO:0011263" DB="MONDO" />
              <XRef Type="MIM" ID="602613" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1377" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="7141" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2C</ElementValue>
                <XRef Type="MIM" ID="606071" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth Neuropathy Type 2C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease axonal type 2C</ElementValue>
                <XRef ID="MONDO:0011633" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth disease type 2C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary motor and sensory neuropathy 2 C</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HMSN IIC</ElementValue>
                <XRef Type="MIM" ID="606071" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">HMSN2C</ElementValue>
                <XRef Type="MIM" ID="606071" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CMT 2C</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HMSN 2 C</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1250" />
                <XRef ID="1250" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The autosomal dominant TRPV4 disorders (previously considered to be clinically distinct phenotypes before their molecular basis was discovered) are now grouped into neuromuscular disorders and skeletal dysplasias; however, the overlap within each group is considerable. Affected individuals typically have either neuromuscular or skeletal manifestations alone, and in only rare instances an overlap syndrome has been reported. The three autosomal dominant neuromuscular disorders (mildest to most severe) are: Charcot-Marie-Tooth disease type 2C. Scapuloperoneal spinal muscular atrophy. Congenital distal spinal muscular atrophy. The autosomal dominant neuromuscular disorders are characterized by a congenital-onset, static, or later-onset progressive peripheral neuropathy with variable combinations of laryngeal dysfunction (i.e., vocal fold paresis), respiratory dysfunction, and joint contractures. The six autosomal dominant skeletal dysplasias (mildest to most severe) are: Familial digital arthropathy-brachydactyly. Autosomal dominant brachyolmia. Spondylometaphyseal dysplasia, Kozlowski type. Spondyloepiphyseal dysplasia, Maroteaux type. Parastremmatic dysplasia. Metatropic dysplasia. The skeletal dysplasia is characterized by brachydactyly (in all 6); the five that are more severe have short stature that varies from mild to severe with progressive spinal deformity and involvement of the long bones and pelvis. In the mildest of the autosomal dominant TRPV4 disorders life span is normal; in the most severe it is shortened. Bilateral progressive sensorineural hearing loss (SNHL) can occur with both autosomal dominant neuromuscular disorders and skeletal dysplasias.</Attribute>
                <XRef ID="NBK201366" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301532</ID>
                <ID Source="BookShelf">NBK1358</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24830047</ID>
                <ID Source="BookShelf">NBK201366</ID>
              </Citation>
              <XRef ID="99937" DB="Orphanet" />
              <XRef ID="C1853710" DB="MedGen" />
              <XRef ID="MONDO:0011633" DB="MONDO" />
              <XRef Type="MIM" ID="606071" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="25479" SubmissionDate="2021-09-07" DateLastUpdated="2023-10-21" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="605427.0016_METATROPIC DYSPLASIA" title="TRPV4, 3-BP DEL, 1411TTC_METATROPIC DYSPLASIA" />
        <ClinVarAccession Accession="SCV000025479" DateUpdated="2023-10-21" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with metatropic dysplasia (MTD; 156530), Dai et al. (2010) identified heterozygosity for a 3-bp deletion (c.1411delTTC) in exon 8 of the TRPV4 gene, resulting in deletion of phe471 (F471del) from the S1 domain. The authors stated that this was the first reported mutation other than a missense mutation in the TRPV4 gene.</Attribute>
              <Citation>
                <ID Source="PubMed">20577006</ID>
              </Citation>
              <XRef DB="OMIM" ID="156530" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient with lethal infantile metatropic dysplasia, Camacho et al. (2010) identified heterozygosity for the F471del mutation, which they described as affecting nucleotides 1412 to 1414.</Attribute>
              <Citation>
                <ID Source="PubMed">20425821</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRPV4" />
          </GeneList>
          <Name>TRPV4, 3-BP DEL, 1411TTC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 1411TTC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605427.0016" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">METATROPIC DYSPLASIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7981616" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4910059|MedGen:C2079540" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004296213" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20425821</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20577006</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22791502</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21573172</ID>
          </Citation>
          <Comment>This variant has been observed in individuals with clinical features of metatropic dysplasia (PMID: 20425821, 20577006, 22791502). This variant is not present in population databases (gnomAD no frequency). This variant, c.1412_1414del, results in the deletion of 1 amino acid(s) of the TRPV4 protein (p.Phe471del), but otherwise preserves the integrity of the reading frame. ClinVar contains an entry for this variant (Variation ID: 126464). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this variant affects TRPV4 function (PMID: 21573172). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRPV4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.110232211_110232213del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2079540" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3097293" SubmissionDate="2021-03-31" DateLastUpdated="2021-05-10" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="UCSF501|OMIM:602613" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001573062" DateUpdated="2021-05-10" DateCreated="2021-05-10" Type="SCV" Version="1" SubmitterName="Genomic Medicine Lab, University of California San Francisco" OrgID="506696" OrganizationCategory="laboratory" OrgAbbreviation="UCSF GML" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Exome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRPV4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_021625.4:c.1412_1414del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602613" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-P3EGS</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9397059</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="267888" SubmissionDate="2014-04-07" DateLastUpdated="2022-10-01" DateCreated="2015-12-21">
        <ClinVarSubmissionID localKey="NM_021625.4:c.1412_1414delTCT|MedGen:C0410528" />
        <ClinVarAccession Accession="SCV000148019" DateUpdated="2022-10-01" DateCreated="2015-12-21" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="BookShelf">NBK201366</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRPV4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_067638.3:p.Phe471del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_021625.4:c.1412_1414delTCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0410528" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GRs_3-6-14</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3849683" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2021-10-08">
        <ClinVarSubmissionID localKey="111003|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001961374" DateUpdated="2024-07-15" DateCreated="2021-10-08" Type="SCV" Version="17" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>TRPV4: PS2, PM2, PS4:Moderate, PM4:Supporting, PS3:Supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRPV4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="12" alternateAllele="T" referenceAllele="TAGA" start="110232210" stop="110232213" variantLength="4" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1731179" SubmissionDate="2018-10-10" DateLastUpdated="2019-02-18" DateCreated="2019-02-18">
        <ClinVarSubmissionID localKey="208521|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000884748" DateUpdated="2019-02-18" DateCreated="2019-02-18" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The TRPV4 c.1412_1414delTCT; p.Phe471del variant (rs515726154, ClinVar variant ID 126464) has been detected in at least two cases of metatropic dysplasia, one of which was infantile lethal (Camacho 2010, Dai 2010). Functional studies in Xenopus oocytes demonstrated that the p.Phe471del variant, like other established pathogenic TRPV4 variants, results in a phenotype consistent with a constitutively open calcium channel compared to wild-type, and similar gain-of-function mutations have been associated with disease in other TRP channel proteins (Loukin 2011). This variant is absent from the general population databases (1000 Genomes Project, Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. Based on the available information, the p.Phe471del variant is likely to be a pathogenic variant associated with metatropic dysplasia.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/w2yp3qyt/arup_molecular_germline_variant_investigation_process.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="12" alternateAllele="-" referenceAllele="AGA" start="110232211" stop="110232213" variantLength="3" />
          </Location>
          <OtherNameList>
            <Name>p.Phe471del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_021625.4:c.1412_1414delTCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4618058</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3097293" TraitType="Disease" MappingType="XRef" MappingValue="602613" MappingRef="OMIM">
        <MedGen CUI="C1865117" Name="Skeletal dysplasia and progressive central nervous system degeneration, lethal" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1731179" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3849683" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7981616" TraitType="Disease" MappingType="XRef" MappingValue="C2079540" MappingRef="MedGen">
        <MedGen CUI="C1853710" Name="Charcot-Marie-Tooth disease axonal type 2C" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="267888" TraitType="Disease" MappingType="XRef" MappingValue="C0410528" MappingRef="MedGen">
        <MedGen CUI="C0410528" Name="Skeletal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="25479" TraitType="Disease" MappingType="Name" MappingValue="METATROPIC DYSPLASIA" MappingRef="Preferred">
        <MedGen CUI="C0265281" Name="Metatropic dysplasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

